Clinical Trial Update: A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating IW-1973 (sGC stimulator) in diabetic nephropathy/diabetic kidney disease, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus with Diabetic Nephropathy

Drugs mentioned

• IW-1973 (IW-1973)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Type 2 Diabetes Mellitus With Diabetic Nephropathy | Phase 2 | Status: COMPLETED | Results posted: 2022-09-15